Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
As of April 2025 Baxter has a market cap of A$24.37 Billion. This makes Baxter the world's 1177th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | A$24.37 B | 1.68% |
2024 | A$23.96 B | -16.74% |
2023 | A$28.78 B | -23.76% |
2022 | A$37.75 B | -36.31% |
2021 | A$59.28 B | 11.22% |
2020 | A$53.30 B | -11.82% |
2019 | A$60.45 B | 26.12% |
2018 | A$47.93 B | 6.25% |
2017 | A$45.11 B | 34.83% |
2016 | A$33.45 B | 16.66% |
2015 | A$28.67 B | -40.95% |
2014 | A$48.57 B | 14.71% |
2013 | A$42.34 B | 20.85% |
2012 | A$35.03 B | 28.76% |
2011 | A$27.21 B | -5.98% |
2010 | A$28.94 B | -26.28% |
2009 | A$39.25 B | -16.66% |
2008 | A$47.10 B | 11.83% |
2007 | A$42.12 B | 10.04% |
2006 | A$38.27 B | 19.05% |
2005 | A$32.15 B | 16.58% |
2004 | A$27.58 B | 9.34% |
2003 | A$25.22 B | -15.34% |
2002 | A$29.79 B | -52.66% |
2001 | A$62.93 B | 35.9% |
2000 | A$46.30 B | 66.94% |
1999 | A$27.74 B | -7.76% |
1998 | A$30.07 B | 38.72% |
1997 | A$21.68 B | 54.19% |
1996 | A$14.06 B |
On Apr 24th, 2025 the market cap of Baxter was reported to be: